IL1RL1变异可能会影响严重喘患者对2型生物制剂的反应
Kenta Nishi1, Hisako Matsumoto1,2, Hironobu Sunadome1
1Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
像IL1RL1 rs1420101和IL4RA rs8832基因型这样的遗传因素可能会预测严重喘患者对生物药物的更好的反应. 这一发现可以个性化严重喘治疗策略.
科学领域:
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
- 药物基因组学 药物基因组学
背景情况:
- 严重的喘表现出不同的治疗反应,受遗传因素的影响.
- 遗传背景对严重喘时生物疗法有效性的影响尚不清楚.
- 了解遗传倾向对于优化严重喘管理至关重要.
研究的目的:
- 研究特定遗传多态性在预测严重喘中生物治疗反应中的作用.
- 确定与严重喘患者最佳生物选择相关的遗传标记.
主要方法:
- 一个多中心,观察性,现实世界的研究,对接受生物药物的严重喘成年人进行了研究.
- 医生对治疗有效性的全球评估 (GETE) 评估了治疗反应.
- 在IL1RL1 (rs1420101),IL4RA (rs8832) 和TSLP (rs1837253) 中分析单核酸多态 (SNPs).
主要成果:
- 46.9%的患者获得了优异的GETE分数,至少有一种生物.
- IL1RL1 rs1420101风险基因型在具有良好反应的患者中更为频繁,特别是对benralizumab.
- 最佳的生物选择因基因型而异:抗IL-5药物用于rs1420101 TT或rs8832 GG,而dupilumab显示出一致的疗效.
结论:
- IL1RL1 rs1420101 TT和IL4RA rs8832 GG基因型可以预测对生物药物的良好反应,特别是抗IL-5疗法.
- 遗传特征可能有助于针对严重喘进行个性化生物治疗选择.
- 阐明遗传倾向可以提高生物时代严重喘的管理.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
08:30Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
Published on: May 10, 2022
相关概念视频
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction
